{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:39:56Z","timestamp":1791038396182,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071021"],"award-info":[{"award-number":["82071021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271147"],"award-info":[{"award-number":["82271147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271146"],"award-info":[{"award-number":["82271146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018532","name":"Major Scientific and Technological Innovation Project of Shandong Province","doi-asserted-by":"publisher","award":["2020CXGC011302"],"award-info":[{"award-number":["2020CXGC011302"]}],"id":[{"id":"10.13039\/501100018532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018532","name":"Major Scientific and Technological Innovation Project of Shandong Province","doi-asserted-by":"publisher","award":["2022CXGC020506"],"award-info":[{"award-number":["2022CXGC020506"]}],"id":[{"id":"10.13039\/501100018532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH177"],"award-info":[{"award-number":["ZR2020MH177"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00405-024-08903-7","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T13:02:16Z","timestamp":1724677336000},"page":"559-569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis"],"prefix":"10.1007","volume":"282","author":[{"given":"Huikang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxue","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xicheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-2629","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"8903_CR1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C et al (2020) European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Rhinology"},{"issue":"8","key":"8903_CR2","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/all.12874","volume":"71","author":"XD Wang","year":"2016","unstructured":"Wang XD, Zheng M, Lou HF et al (2016) An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy 71(8):1170\u20131180. https:\/\/doi.org\/10.1111\/all.12874","journal-title":"Allergy"},{"key":"8903_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2024.100211","author":"Z Liu","year":"2024","unstructured":"Liu Z, Yao Y, Xie H et al (2024) Visual and bibliometric analysis of chronic rhinosinusitis and nasal polyps. J Allergy Clin Immunol Glob. https:\/\/doi.org\/10.1016\/j.jacig.2024.100211","journal-title":"J Allergy Clin Immunol Glob"},{"key":"8903_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23331","author":"X Gong","year":"2024","unstructured":"Gong X, Fu Y, Zhou L et al (2024) Decoding chronic rhinosinusitis: a metabolomics-based approach. Int Forum Allergy Rhinol. https:\/\/doi.org\/10.1002\/alr.23331","journal-title":"Int Forum Allergy Rhinol"},{"key":"8903_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.663","author":"J Behnke","year":"2024","unstructured":"Behnke J, Dundervill C, Al-Asadi Z, Shahid M, Ramadan HH, Makary CA (2024) Gender differences in adults with chronic rhinosinusitis: a scoping review. Otolaryngol Head Neck Surg. https:\/\/doi.org\/10.1002\/ohn.663","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"8903_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000529918","volume":"85","author":"HY Hong","year":"2023","unstructured":"Hong HY, Chen TY, Yang QT et al (2023) Chinese expert consensus on the use of biologics in patients with chronic Rhinosinusitis (2022, Zhuhai). ORL J Otorhinolaryngol Relat Spec 85(3):128\u2013140. https:\/\/doi.org\/10.1159\/000529918","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"11","key":"8903_CR7","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/life13112165","volume":"13","author":"R Cergan","year":"2023","unstructured":"Cergan R, Berghi ON, Dumitru M, Vrinceanu D, Manole F, Serboiu CS (2023) Biologics for chronic rhinosinusitis-a modern option for therapy. Life (Basel). 13(11):2165. https:\/\/doi.org\/10.3390\/life13112165","journal-title":"Life (Basel)."},{"issue":"1","key":"8903_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ACI.0000000000000954","volume":"24","author":"J Bai","year":"2024","unstructured":"Bai J, Tan BK, Kato A (2024) Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 24(1):1\u20138. https:\/\/doi.org\/10.1097\/ACI.0000000000000954","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"8903_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/all.15074","volume":"77","author":"A Kato","year":"2022","unstructured":"Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC (2022) Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy 77(3):812\u2013826. https:\/\/doi.org\/10.1111\/all.15074","journal-title":"Allergy"},{"issue":"1","key":"8903_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.anl.2023.08.002","volume":"51","author":"T Tsuda","year":"2024","unstructured":"Tsuda T, Suzuki M, Kato Y et al (2024) The current findings in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx 51(1):51\u201360. https:\/\/doi.org\/10.1016\/j.anl.2023.08.002","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"8903_CR11","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","volume":"138","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang N, Bo M et al (2016) Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol 138(5):1344\u20131353. https:\/\/doi.org\/10.1016\/j.jaci.2016.05.041","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"8903_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11882-023-01114-w","volume":"23","author":"CL Guo","year":"2023","unstructured":"Guo CL, Liu FF, Wang DY, Liu Z (2023) Type 2 biomarkers for the indication and response to biologics in CRSwNP. Curr Allergy Asthma Rep 23(12):703\u2013713. https:\/\/doi.org\/10.1007\/s11882-023-01114-w","journal-title":"Curr Allergy Asthma Rep"},{"issue":"8","key":"8903_CR13","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/1744666X.2023.2206120","volume":"19","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhang N, Bachert C (2023) Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps. Expert Rev Clin Immunol 19(8):837\u2013845. https:\/\/doi.org\/10.1080\/1744666X.2023.2206120","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"8903_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40259-023-00602-9","volume":"37","author":"N Haloob","year":"2023","unstructured":"Haloob N, Karamali K, Hopkins C (2023) The role of biologics in the treatment of chronic rhinosinusitis. BioDrugs 37(4):477\u2013487. https:\/\/doi.org\/10.1007\/s40259-023-00602-9","journal-title":"BioDrugs"},{"issue":"5","key":"8903_CR15","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.3390\/ijms24055015","volume":"24","author":"SD Kim","year":"2023","unstructured":"Kim SD, Cho KS (2023) Treatment strategy of uncontrolled chronic rhinosinusitis with nasal polyps: a review of recent evidence. Int J Mol Sci 24(5):5015. https:\/\/doi.org\/10.3390\/ijms24055015","journal-title":"Int J Mol Sci"},{"issue":"7","key":"8903_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement [J]. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"issue":"11","key":"8903_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777\u2013784. https:\/\/doi.org\/10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"8903_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000142","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ et al (2019) Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.ED000142","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"8903_CR19","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.3390\/jcm10245723","volume":"10","author":"O Fahmy","year":"2021","unstructured":"Fahmy O, Fahmy UA, Alhakamy NA, Khairul-Asri MG (2021) Single-port versus multiple-port robot-assisted radical prostatectomy: a systematic review and meta-analysis. J Clin Med 10(24):5723. https:\/\/doi.org\/10.3390\/jcm10245723","journal-title":"J Clin Med"},{"issue":"10","key":"8903_CR20","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"A Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G (2013) Graphical tools for network meta-analysis in STATA. PLoS ONE 8(10):e76654. https:\/\/doi.org\/10.1371\/journal.pone.0076654","journal-title":"PLoS ONE"},{"issue":"2","key":"8903_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64(2):163\u2013171. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.03.016","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"8903_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jrsm.57","volume":"3","author":"A Chaimani","year":"2012","unstructured":"Chaimani A, Salanti G (2012) Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions. Res Synth Methods 3(2):161\u2013176. https:\/\/doi.org\/10.1002\/jrsm.57","journal-title":"Res Synth Methods"},{"issue":"6","key":"8903_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/cea.13852","volume":"51","author":"J Tversky","year":"2021","unstructured":"Tversky J, Lane AP, Azar A (2021) Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): a randomized double-blind placebo-controlled trial. Clin Exp Allergy 51(6):836\u2013844. https:\/\/doi.org\/10.1111\/cea.13852","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"8903_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/all.14902","volume":"77","author":"GW Canonica","year":"2022","unstructured":"Canonica GW, Harrison TW, Chanez P et al (2022) Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy 77(1):150\u2013161. https:\/\/doi.org\/10.1111\/all.14902","journal-title":"Allergy"},{"issue":"6","key":"8903_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/19458924211009429","volume":"35","author":"T Takabayashi","year":"2021","unstructured":"Takabayashi T, Asaka D, Okamoto Y et al (2021) A phase II, multicenter, randomized, placebo-controlled study of Benralizumab, a Humanized anti-IL-5R alpha monoclonal antibody, in patients with eosinophilic chronic rhinosinusitis. Am J Rhinol Allergy 35(6):861\u2013870. https:\/\/doi.org\/10.1177\/19458924211009429","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"8903_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","volume":"149","author":"C Bachert","year":"2022","unstructured":"Bachert C, Han JK, Desrosiers MY et al (2022) Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial. J Allergy Clin Immunol 149(4):1309-1317.e12. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.030","journal-title":"J Allergy Clin Immunol"},{"key":"8903_CR27","doi-asserted-by":"publisher","unstructured":"Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials [published correction appears in Lancet. 2019 Nov 2;394(10209):1618].\u00a0Lancet.;394(10209):1638\u20131650. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1.","DOI":"10.1016\/S0140-6736(19)31881-1"},{"issue":"1","key":"8903_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/all.13984","volume":"75","author":"C Bachert","year":"2020","unstructured":"Bachert C, Hellings PW, Mullol J et al (2020) Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy 75(1):148\u2013157. https:\/\/doi.org\/10.1111\/all.13984","journal-title":"Allergy"},{"issue":"3","key":"8903_CR29","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jaip.2020.12.059","volume":"9","author":"M Boguniewicz","year":"2021","unstructured":"Boguniewicz M, Beck LA, Sher L et al (2021) Dupilumab improves asthma and sinonasal outcomes in adults with moderate to severe atopic dermatitis. J Allergy Clin Immunol Pract 9(3):1212-1223.e6. https:\/\/doi.org\/10.1016\/j.jaip.2020.12.059","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"8903_CR30","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.jaip.2022.02.026","volume":"10","author":"GW Canonica","year":"2022","unstructured":"Canonica GW, Bourdin A, Peters AT et al (2022) Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases. J Allergy Clin Immunol Pract 10(6):1515\u20131526. https:\/\/doi.org\/10.1016\/j.jaip.2022.02.026","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"8903_CR31","doi-asserted-by":"publisher","first-page":"E1770","DOI":"10.1002\/lary.29230","volume":"131","author":"S Fujieda","year":"2021","unstructured":"Fujieda S, Matsune S, Takeno S et al (2021) The Effect of dupilumab on intractable chronic rhinosinusitis with nasal polyps in Japan. Laryngoscope 131(6):E1770\u2013E1777. https:\/\/doi.org\/10.1002\/lary.29230","journal-title":"Laryngoscope"},{"issue":"6","key":"8903_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4193\/Rhin22.129","volume":"60","author":"BR Haxel","year":"2022","unstructured":"Haxel BR, Hummel T, Fruth K et al (2022) Real-world-effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps. Rhinology 60(6):435\u2013443. https:\/\/doi.org\/10.4193\/Rhin22.129","journal-title":"Rhinology"},{"issue":"4","key":"8903_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/all.13685","volume":"74","author":"K Jonstam","year":"2019","unstructured":"Jonstam K, Swanson BN, Mannent LP et al (2019) Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Allergy 74(4):743\u2013752. https:\/\/doi.org\/10.1111\/all.13685","journal-title":"Allergy"},{"issue":"5","key":"8903_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.anai.2021.01.012","volume":"126","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM, Bachert C, Amin N et al (2021) Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy Asthma Immunol 126(5):584-592.e1. https:\/\/doi.org\/10.1016\/j.anai.2021.01.012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"8903_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jaip.2019.07.016","volume":"8","author":"JF Maspero","year":"2020","unstructured":"Maspero JF, Katelaris CH, Busse WW et al (2020) Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with Self-reported chronic rhinosinusitis. J Allergy Clin Immunol Pract 8(2):527-539.e9. https:\/\/doi.org\/10.1016\/j.jaip.2019.07.016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"8903_CR36","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaci.2021.07.045","volume":"149","author":"P Gevaert","year":"2022","unstructured":"Gevaert P, Saenz R, Corren J et al (2022) Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study. J Allergy Clin Immunol 149(3):957-965.e3. https:\/\/doi.org\/10.1016\/j.jaci.2021.07.045","journal-title":"J Allergy Clin Immunol"},{"key":"8903_CR37","doi-asserted-by":"publisher","unstructured":"Gevaert P, Omachi TA, Corren J, et al. 2020 Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials [published correction appears in J Allergy Clin Immunol. 2021 Jan;147(1):416].\u00a0J Allergy Clin Immunol.;146(3):595\u2013605. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.032.","DOI":"10.1016\/j.jaci.2020.05.032"},{"issue":"1","key":"8903_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","volume":"131","author":"P Gevaert","year":"2013","unstructured":"Gevaert P, Calus L, Van Zele T et al (2013) Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131(1):110\u20136.e1. https:\/\/doi.org\/10.1016\/j.jaci.2012.07.047","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8903_CR39","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","volume":"140","author":"C Bachert","year":"2017","unstructured":"Bachert C, Sousa AR, Lund VJ et al (2017) Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol 140(4):1024-1031.e14. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.044","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8903_CR40","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","volume":"128","author":"P Gevaert","year":"2011","unstructured":"Gevaert P, Van Bruaene N, Cattaert T et al (2011) Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 128(5):989\u201395.e958. https:\/\/doi.org\/10.1016\/j.jaci.2011.07.056","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8903_CR41","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/all.15434","volume":"78","author":"WJ Fokkens","year":"2023","unstructured":"Fokkens WJ, Mullol J, Kennedy D et al (2023) Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In-depth sinus surgery analysis. Allergy 78(3):812\u2013821. https:\/\/doi.org\/10.1111\/all.15434","journal-title":"Allergy"},{"issue":"3","key":"8903_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000519228","volume":"183","author":"Q Wu","year":"2022","unstructured":"Wu Q, Zhang Y, Kong W et al (2022) Which is the best biologic for Nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis. Int Arch Allergy Immunol 183(3):279\u2013288. https:\/\/doi.org\/10.1159\/000519228","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"8903_CR43","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jaip.2022.02.034","volume":"10","author":"S Cai","year":"2022","unstructured":"Cai S, Xu S, Lou H, Zhang L (2022) Comparison of different biologics for treating chronic rhinosinusitis with nasal polyps: a network analysis. J Allergy Clin Immunol Pract 10(7):1876-1886.e7. https:\/\/doi.org\/10.1016\/j.jaip.2022.02.034","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"8903_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.anai.2019.07.004","volume":"123","author":"CD Codispoti","year":"2019","unstructured":"Codispoti CD, Mahdavinia M (2019) A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps. Ann Allergy Asthma Immunol 123(3):232\u2013239. https:\/\/doi.org\/10.1016\/j.anai.2019.07.004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"8903_CR45","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/alr.22774","volume":"11","author":"S Bajpai","year":"2021","unstructured":"Bajpai S, Marino MJ, Rank MA, Donaldson AM, O\u2019Brien EK, Lal D (2021) Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: a real-world study. Int Forum Allergy Rhinol 11(8):1152\u20131161. https:\/\/doi.org\/10.1002\/alr.22774","journal-title":"Int Forum Allergy Rhinol"},{"key":"8903_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2024.101394","author":"WT Anselmo-Lima","year":"2024","unstructured":"Anselmo-Lima WT, Romano FR, Tamashiro E et al (2024) Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps-2024 update. Braz J Otorhinolaryngol. https:\/\/doi.org\/10.1016\/j.bjorl.2024.101394","journal-title":"Braz J Otorhinolaryngol"},{"issue":"7","key":"8903_CR47","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.jaip.2023.04.033","volume":"11","author":"J S\u00e1nchez","year":"2023","unstructured":"S\u00e1nchez J, Garc\u00eda E, Lopez JF, Calle A, Buendia JA (2023) Nonsteroidal anti-inflammatory drug (NSAID) tolerance after biological therapy in patients With NSAID-exacerbated respiratory disease: a randomized comparative trial. J Allergy Clin Immunol Pract 11(7):2172\u20132179. https:\/\/doi.org\/10.1016\/j.jaip.2023.04.033","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"8903_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/alr.23234","volume":"14","author":"GX Papacharalampous","year":"2024","unstructured":"Papacharalampous GX, Constantinidis J, Fotiadis G, Zhang N, Bachert C, Katotomichelakis M (2024) Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare agents\u2019 efficacy. Int Forum Allergy Rhinol 14(1):96\u2013109. https:\/\/doi.org\/10.1002\/alr.23234","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"8903_CR49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4193\/Rhin22.412","volume":"61","author":"HH Kariyawasam","year":"2023","unstructured":"Kariyawasam HH, Chandrasekharan DP, Jacques T et al (2023) Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Rhinology 61(2):98\u2013107. https:\/\/doi.org\/10.4193\/Rhin22.412","journal-title":"Rhinology"},{"issue":"4","key":"8903_CR50","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","volume":"149","author":"P Oykhman","year":"2022","unstructured":"Oykhman P, Paramo FA, Bousquet J, Kennedy DW, Brignardello-Petersen R, Chu DK (2022) Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. J Allergy Clin Immunol 149(4):1286\u20131295. https:\/\/doi.org\/10.1016\/j.jaci.2021.09.009","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8903_CR51","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/all.14235","volume":"75","author":"I Agache","year":"2020","unstructured":"Agache I, Rocha C, Beltran J et al (2020) Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI guidelines-recommendations on the use of biologicals in severe asthma. Allergy 75(5):1043\u20131057. https:\/\/doi.org\/10.1111\/all.14235","journal-title":"Allergy"},{"issue":"7","key":"8903_CR52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S2213-2600(17)30190-X","volume":"5","author":"GT Ferguson","year":"2017","unstructured":"Ferguson GT, FitzGerald JM, Bleecker ER et al (2017) Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 5(7):568\u2013576. https:\/\/doi.org\/10.1016\/S2213-2600(17)30190-X","journal-title":"Lancet Respir Med"},{"issue":"5","key":"8903_CR53","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jaci.2021.10.040","volume":"149","author":"C Bachert","year":"2022","unstructured":"Bachert C, Sousa AR, Han JK et al (2022) Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count. J Allergy Clin Immunol 149(5):1711-1721.e6. https:\/\/doi.org\/10.1016\/j.jaci.2021.10.040","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"8903_CR54","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1159\/000514262","volume":"182","author":"EC Meier","year":"2021","unstructured":"Meier EC, Schmid-Grendelmeier P, Steiner UC, Soyka MB (2021) Real-life experience of monoclonal antibody treatments in chronic rhinosinusitis with nasal polyposis. Int Arch Allergy Immunol 182(8):736\u2013743. https:\/\/doi.org\/10.1159\/000514262","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"8903_CR55","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jaci.2022.11.021","volume":"151","author":"T Nopsopon","year":"2023","unstructured":"Nopsopon T, Lassiter G, Chen ML et al (2023) Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. J Allergy Clin Immunol 151(3):747\u2013755. https:\/\/doi.org\/10.1016\/j.jaci.2022.11.021","journal-title":"J Allergy Clin Immunol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08903-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:46:43Z","timestamp":1738936003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08903-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["8903"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08903-7","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"12 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}